Literature DB >> 6267229

Fast attempts at the photodynamic treatment of human gliomas.

C Perria, T Capuzzo, G Cavagnaro, R Datti, N Francaviglia, C Rivano, V E Tercero.   

Abstract

Photodynamic therapy is based on the capacity of certain substances to preferentially stain neoplastic tissues in respect to healthy tissues, and on the property of such substances to produce cytotoxic agents when excited by light of an appropriate wavelength. The authors demonstrate the first attempts to photoradiant therapy in the treatment of human gliomas utilizing a hematoporphyrin derivative injected i.v. as a sensitizing drug. A He Ne Laser (632,8 nm) was used in order to trigger the photodynamic process. Immediately after surgical removal of the glioma the residual tumoral bed was exposed to the action of the Laser in order to provoke necrosis of the remaining neoplastic cells. Necrosis even if partial of the residual tumor was effected. Better and more definite results may be obtained in the future utilizing a Laser connected with fiber optics consenting an in-depth light penetration.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6267229

Source DB:  PubMed          Journal:  J Neurosurg Sci        ISSN: 0390-5616            Impact factor:   2.279


  12 in total

1.  Predictors and Limitations of the Penetration Depth of Photodynamic Effects in the Rodent Brain.

Authors:  Collin T Inglut; Brandon Gaitan; Daniel Najafali; Irati Abad Lopez; Nina P Connolly; Seppo Orsila; Robert Perttilä; Graeme F Woodworth; Yu Chen; Huang-Chiao Huang
Journal:  Photochem Photobiol       Date:  2019-10-13       Impact factor: 3.421

Review 2.  Photodynamic therapy of cancer: an update.

Authors:  Patrizia Agostinis; Kristian Berg; Keith A Cengel; Thomas H Foster; Albert W Girotti; Sandra O Gollnick; Stephen M Hahn; Michael R Hamblin; Asta Juzeniene; David Kessel; Mladen Korbelik; Johan Moan; Pawel Mroz; Dominika Nowis; Jacques Piette; Brian C Wilson; Jakub Golab
Journal:  CA Cancer J Clin       Date:  2011-05-26       Impact factor: 508.702

Review 3.  A Surgical View of Photodynamic Therapy in Oncology: A Review.

Authors:  K Moghissi; Kate Dixon; Sally Gibbins
Journal:  Surg J (N Y)       Date:  2015-10-15

4.  Observations in studies of quantitative kinetics of tritium labelled hematoporphyrin derivatives (HpDI and HpDII) in the normal and neoplastic rat brain model.

Authors:  F M Little; C J Gomer; S Hyman; M L Apuzzo
Journal:  J Neurooncol       Date:  1984       Impact factor: 4.130

5.  Photoradiation therapy of 9L-gliosarcoma in rats: hematoporphyrin derivative (types I and II) followed by laser energy.

Authors:  M K Cheng; J McKean; B Mielke; J Tulip; D Boisvert
Journal:  J Neurooncol       Date:  1985       Impact factor: 4.130

6.  Penetration of hematoporphyrin derivative into rat brain and intracerebral 9L glioma tissue.

Authors:  D P Boisvert; J D McKean; J Tulip; J Cummins; M K Cheng
Journal:  J Neurooncol       Date:  1985       Impact factor: 4.130

7.  Uptake and retention of the photosensitizer mono-L-asparthyl chlorine e6 in experimental malignant glioma.

Authors:  Hiroyuki Matsumura; Jiro Akimoto; Jo Haraoka; Katsuo Aizawa
Journal:  Lasers Med Sci       Date:  2007-08-17       Impact factor: 3.161

8.  DWI for Monitoring the Acute Response of Malignant Gliomas to Photodynamic Therapy.

Authors:  Y Fujita; T Sasayama; K Tanaka; K Kyotani; H Nagashima; M Kohta; H Kimura; A Fujita; E Kohmura
Journal:  AJNR Am J Neuroradiol       Date:  2019-11-21       Impact factor: 3.825

9.  Selective necrosis of malignant gliomas in mice using photodynamic therapy.

Authors:  D R Sandeman; R Bradford; P Buxton; S G Bown; D G Thomas
Journal:  Br J Cancer       Date:  1987-06       Impact factor: 7.640

10.  Photodynamic therapy of a mouse glioma: intracranial tumours are resistant while subcutaneous tumours are sensitive.

Authors:  E A Lindsay; M C Berenbaum; R Bonnett; D G Thomas
Journal:  Br J Cancer       Date:  1991-02       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.